Aveo Capital Partners, LLC Amgen Inc Transaction History

Aveo Capital Partners, LLC

$844 Million
Q2 2024

A detailed history of Aveo Capital Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aveo Capital Partners, LLC holds 2,265 shares of AMGN stock, worth $715,740. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,265

Previous 2,859 20.78%

Holding current value

$715,740

Previous $812,000 12.93%

% of portfolio

0.08%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $156,073 - $189,670	-594 Reduced 20.78%	2,265 $707,000
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $34,953 - $42,192	130 Added 4.76%	2,859 $812,000
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $115,832 - $130,672	453 Added 19.9%	2,729 $786,000
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $105,170 - $130,572	481 Added 26.8%	2,276 $611,000
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $70,923 - $83,865	331 Added 22.61%	1,795 $398,000
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $451 - $550	-2 Reduced 0.14%	1,464 $353,000
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $76,954 - $97,779	-336 Reduced 18.65%	1,466 $385,000
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $673 - $759	-3 Reduced 0.17%	1,802 $406,000
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $18,687 - $20,795	-81 Reduced 4.29%	1,805 $439,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $14,691 - $16,252	67 Added 3.68%	1,886 $456,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $7,159 - $8,193	36 Added 2.02%	1,819 $409,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $1,273 - $1,492	6 Added 0.34%	1,783 $379,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $76,380 - $84,738	327 Added 22.55%	1,777 $433,000
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $321,769 - $374,970	1,450 New	1,450 $361,000
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $452,666 - $539,045	-2,092 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $490,887 - $545,907	2,092 New	2,092 $532,000
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $595,210 - $730,404	-3,009 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $8,929 - $11,843	49 Added 1.66%	3,009 $610,000
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $88,621 - $106,187	-509 Reduced 14.67%	2,960 $635,000
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $13,502 - $15,828	81 Added 2.39%	3,469 $610,000
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $153,377 - $172,890	848 Added 33.39%	3,388 $644,000
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $5,887 - $6,872	-33 Reduced 1.28%	2,540 $494,000
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $164,537 - $185,494	-888 Reduced 25.66%	2,573 $510,000
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $36,863 - $41,405	-222 Reduced 6.03%	3,461 $639,000
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $44,729 - $52,272	-264 Reduced 6.69%	3,683 $628,000
Q4 2017 Feb 05, 2018	SELL	$168.79 - $188.59 $2,025 - $2,263	-12 Reduced 0.3%	3,947 $686,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $662,301 - $756,169	3,959	3,959 $738,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aveo Capital Partners, LLC with notifications on news.

Account

Aveo Capital Partners, LLC Amgen Inc Transaction History